Literature DB >> 22042812

Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease.

Monika L Gloviczki1, James F Glockner, John A Crane, Michael A McKusick, Sanjay Misra, Joseph P Grande, Lilach O Lerman, Stephen C Textor.   

Abstract

Atherosclerotic renal artery stenosis has a range of manifestations depending on the severity of vascular occlusion. The aim of this study was to examine whether exceeding the limits of adaptation to reduced blood flow ultimately leads to tissue hypoxia, as determined by blood oxygen level dependent MRI. We compared 3 groups of hypertensive patients, 24 with essential hypertension, 13 with "moderate" (Doppler velocities 200-384 cm/s), and 17 with "severe" atherosclerotic renal artery stenosis (ARAS; velocities >384 cm/s and loss of functional renal tissue). Cortical and medullary blood flows and volumes were determined by multidetector computed tomography. Poststenotic kidney size and blood flow were reduced with ARAS, and tissue perfusion fell in the most severe lesions. Tissue medullary deoxyhemoglobin, as reflected by R2* values, was higher as compared with the cortex for all of the groups and did not differ between subjects with renal artery lesions and essential hypertension. By contrast, cortical R2* levels were elevated for severe ARAS (21.6±9.4 per second) as compared with either essential hypertension (17.8±2.3 per second; P<0.01) or moderate ARAS (15.7±2.1 per second; P<0.01). Changes in medullary R2* after furosemide administration tended to be blunted in severe ARAS as compared with unaffected (contralateral) kidneys. These results demonstrate that severe vascular occlusion overwhelms the capacity of the kidney to adapt to reduced blood flow, manifest as overt cortical hypoxia as measured by blood oxygen level-dependent MRI. The level of cortical hypoxia is out of proportion to the medulla and may provide a marker to identify irreversible parenchymal injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042812      PMCID: PMC3904290          DOI: 10.1161/HYPERTENSIONAHA.111.171405

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  39 in total

1.  The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods.

Authors:  Timothy P Murphy; Christopher J Cooper; Lance D Dworkin; William L Henrich; John H Rundback; Alan H Matsumoto; Kenneth A Jamerson; Ralph B D'Agostino
Journal:  J Vasc Interv Radiol       Date:  2005-10       Impact factor: 3.464

Review 2.  Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis.

Authors:  Roger G Evans; Bruce S Gardiner; David W Smith; Paul M O'Connor
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-11

3.  Are kidneys not ischemic in human renal vascular disease?

Authors:  Robert M Carey
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

Review 4.  Oxygen and renal metabolism.

Authors:  F H Epstein
Journal:  Kidney Int       Date:  1997-02       Impact factor: 10.612

5.  Ultrasound velocity criteria for renal in-stent restenosis.

Authors:  Yung-Wei Chi; Christopher J White; Stanley Thornton; Richard V Milani
Journal:  J Vasc Surg       Date:  2009-02-23       Impact factor: 4.268

6.  Revascularization versus medical therapy for renal-artery stenosis.

Authors:  Keith Wheatley; Natalie Ives; Richard Gray; Philip A Kalra; Jonathan G Moss; Colin Baigent; Susan Carr; Nicholas Chalmers; David Eadington; George Hamilton; Graham Lipkin; Anthony Nicholson; John Scoble
Journal:  N Engl J Med       Date:  2009-11-12       Impact factor: 91.245

7.  Increased hypoxia and reduced renal tubular response to furosemide detected by BOLD magnetic resonance imaging in swine renovascular hypertension.

Authors:  Sabas I Gomez; Lizette Warner; John A Haas; Rodney J Bolterman; Stephen C Textor; Lilach O Lerman; Juan Carlos Romero
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-29

Review 8.  Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease.

Authors:  Samuel N Heyman; Mogher Khamaisi; Seymour Rosen; Christian Rosenberger
Journal:  Am J Nephrol       Date:  2008-07-18       Impact factor: 3.754

9.  Endothelial progenitor cells restore renal function in chronic experimental renovascular disease.

Authors:  Alejandro R Chade; Xiangyang Zhu; Ronit Lavi; James D Krier; Sorin Pislaru; Robert D Simari; Claudio Napoli; Amir Lerman; Lilach O Lerman
Journal:  Circulation       Date:  2009-01-19       Impact factor: 29.690

10.  Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial.

Authors:  Liesbeth Bax; Arend-Jan J Woittiez; Hans J Kouwenberg; Willem P T M Mali; Erik Buskens; Frederik J A Beek; Branko Braam; Frans T M Huysmans; Leo J Schultze Kool; Matthieu J C M Rutten; Cornelius J Doorenbos; Johannes C N M Aarts; Ton J Rabelink; Pierre-François Plouin; Alain Raynaud; Gert A van Montfrans; Jim A Reekers; Anton H van den Meiracker; Peter M T Pattynama; Peter J G van de Ven; Dammis Vroegindeweij; Abraham A Kroon; Michiel W de Haan; Cornelis T Postma; Jaap J Beutler
Journal:  Ann Intern Med       Date:  2009-05-04       Impact factor: 25.391

View more
  52 in total

Review 1.  Renal relevant radiology: renal functional magnetic resonance imaging.

Authors:  Behzad Ebrahimi; Stephen C Textor; Lilach O Lerman
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 8.237

Review 2.  Renovascular hypertension: is there still a role for stent revascularization?

Authors:  Stephen C Textor
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-09       Impact factor: 2.894

Review 3.  Renal artery stenosis: medical versus interventional therapy.

Authors:  Stephen C Textor; Lilach O Lerman
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

Review 4.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

Review 5.  Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy.

Authors:  Junjie Chen; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

6.  Determination of Single-Kidney Glomerular Filtration Rate in Human Subjects by Using CT.

Authors:  Soon Hyo Kwon; Ahmed Saad; Sandra M Herrmann; Stephen C Textor; Lilach O Lerman
Journal:  Radiology       Date:  2015-04-06       Impact factor: 11.105

7.  BOLD-MRI evaluation of subcutaneous and visceral adipose tissue oxygenation status: effect of dietary salt intake.

Authors:  Fei Yuan; Zhao-Zeng Guo; Wen-Jie Ji; Yong-Qiang Ma; Zhuoli Zhang; Xin Zhou; Yu-Ming Li
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

8.  TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis.

Authors:  Monika L Gloviczki; Mira T Keddis; Vesna D Garovic; Hanna Friedman; Sandra Herrmann; Michael A McKusick; Sanjay Misra; Joseph P Grande; Lilach O Lerman; Stephen C Textor
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-20       Impact factor: 8.237

Review 9.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

Review 10.  Emerging Paradigms in Chronic Kidney Ischemia.

Authors:  Alfonso Eirin; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.